Terms: = Skin cancer AND TNFRSF17, BCMA, 608, ENSG00000048462, CD269, Q02223, BCM
78 results:
1. Digital pathology for reporting histopathology samples, including cancer screening samples - definitive evidence from a multisite study.
Azam AS; Tsang YW; Thirlwall J; Kimani PK; Sah S; Gopalakrishnan K; Boyd C; Loughrey MB; Kelly PJ; Boyle DP; Salto-Tellez M; Clark D; Ellis IO; Ilyas M; Rakha E; Bickers A; Roberts ISD; Soares MF; Neil DAH; Takyi A; Raveendran S; Hero E; Evans H; Osman R; Fatima K; Hughes RW; McIntosh SA; Moran GW; Ortiz-Fernandez-Sordo J; Rajpoot NM; Storey B; Ahmed I; Dunn JA; Hiller L; Snead DRJ
Histopathology; 2024 Apr; 84(5):847-862. PubMed ID: 38233108
[TBL] [Abstract] [Full Text] [Related]
2. Immunotherapy targeting B cells and long-lived plasma cells effectively eliminates pre-existing donor-specific allo-antibodies.
Zhang Z; Markmann C; Yu M; Agarwal D; Rostami S; Wang W; Liu C; Zhao H; Ochoa T; Parvathaneni K; Xu X; Li E; Gonzalez V; Khadka R; Hoffmann J; Knox JJ; Scholler J; Marcellus B; Allman D; Fraietta JA; Samelson-Jones B; Milone MC; Monos D; Garfall AL; Naji A; Bhoj VG
Cell Rep Med; 2023 Dec; 4(12):101336. PubMed ID: 38118406
[TBL] [Abstract] [Full Text] [Related]
3. Treatment of Internal Mammary Nodes is Associated With Improved Overall Survival in Breast cancer: A Meta-Analysis.
Shaikh PM; Mulherkar R; Khasawneh MT; Clump D; Hazard-Jenkins H; Hafez M; Vargo JA
Am J Clin Oncol; 2024 Feb; 47(2):81-87. PubMed ID: 37916961
[TBL] [Abstract] [Full Text] [Related]
4. Swallowing disorders and mortality in adults with advanced cancer outside the head and neck and upper gastrointestinal tract: a systematic review.
Silva DNM; Vicente LCC; Glória VLP; de Lima Friche AA
BMC Palliat Care; 2023 Oct; 22(1):150. PubMed ID: 37798715
[TBL] [Abstract] [Full Text] [Related]
5. EV-301 long-term outcomes: 24-month findings from the phase III trial of enfortumab vedotin versus chemotherapy in patients with previously treated advanced urothelial carcinoma.
Rosenberg JE; Powles T; Sonpavde GP; Loriot Y; Duran I; Lee JL; Matsubara N; Vulsteke C; Castellano D; Mamtani R; Wu C; Matsangou M; Campbell M; Petrylak DP
Ann Oncol; 2023 Nov; 34(11):1047-1054. PubMed ID: 37678672
[TBL] [Abstract] [Full Text] [Related]
6. Anti-bcma surface engineered biomimetic photothermal nanomissile enhances multiple myeloma cell apoptosis and overcomes the disturbance of NF-κB signaling in vivo.
Xiao X; Ma Z; Li Z; Deng Y; Zhang Y; Xiang R; Zhu L; He Y; Li H; Jiang Y; Zhu Y; Xie Y; Peng H; Liu X; Wang H; Ye M; Zhao Y; Liu J
Biomaterials; 2023 Jun; 297():122096. PubMed ID: 37075614
[TBL] [Abstract] [Full Text] [Related]
7. Chronic Use of Hydrochlorothiazide and Risk of skin cancer in Caucasian Adults: A PharmLines Initiative Inception Cohort Study.
Haisma MS; Greven N; Logendran M; Bos J; van der Vegt B; Horváth B; De Vos S; De Bock GH; Hak E; Rácz E
Acta Derm Venereol; 2023 Apr; 103():adv3933. PubMed ID: 37014269
[TBL] [Abstract] [Full Text] [Related]
8. Safety and efficacy of Pucotenlimab (HX008) - a humanized immunoglobulin G4 monoclonal antibody in patients with locally advanced or metastatic melanoma: a single-arm, multicenter, phase II study.
Cui C; Chen Y; Luo Z; Zou Z; Jiang Y; Pan H; Fan Q; Zhao J; Xu Q; Jiang R; Wang X; Ma T; Guo Z; Si L; Chi Z; Sheng X; Dou Y; Tan Q; Wu D; Guo J
BMC Cancer; 2023 Feb; 23(1):121. PubMed ID: 36747118
[TBL] [Abstract] [Full Text] [Related]
9. GATA3 Expression in Human Tumors: A Tissue Microarray Study on 16,557 Tumors.
Reiswich V; Schmidt CE; Lennartz M; Höflmayer D; Hube-Magg C; Weidemann S; Fraune C; Büscheck F; Möller K; Bernreuther C; Simon R; Clauditz TS; Blessin NC; Bady E; Sauter G; Uhlig R; Steurer S; Minner S; Burandt E; Dum D; Marx AH; Krech T; Lebok P; Hinsch A; Jacobsen F
Pathobiology; 2023; 90(4):219-232. PubMed ID: 36649695
[TBL] [Abstract] [Full Text] [Related]
10. Desmoglein 3 (Dsg3) expression in cancer: A tissue microarray study on 15,869 tumors.
Viehweger F; Azem A; Gorbokon N; Uhlig R; Lennartz M; Dwertmann Rico S; Kind S; Reiswich V; Kluth M; Hube-Magg C; Bernreuther C; Büscheck F; Clauditz TS; Fraune C; Jacobsen F; Krech T; Lebok P; Steurer S; Burandt E; Minner S; Marx AH; Simon R; Sauter G; Menz A; Hinsch A
Pathol Res Pract; 2022 Dec; 240():154200. PubMed ID: 36375372
[TBL] [Abstract] [Full Text] [Related]
11. Triple MAPK inhibition salvaged a relapsed post-bcma CAR-T cell therapy multiple myeloma patient with a BRAF V600E subclonal mutation.
Elnaggar M; Agte S; Restrepo P; Ram M; Melnekoff D; Adamopoulos C; Stevens MM; Kappes K; Leshchenko V; Verina D; Jagannath S; Poulikakos PI; Parekh S; Laganà A
J Hematol Oncol; 2022 Aug; 15(1):109. PubMed ID: 35978321
[TBL] [Abstract] [Full Text] [Related]
12. T-cell-engaging antibodies for the treatment of solid tumors: challenges and opportunities.
Baeuerle PA; Wesche H
Curr Opin Oncol; 2022 Sep; 34(5):552-558. PubMed ID: 35880455
[TBL] [Abstract] [Full Text] [Related]
13. Cost-effectiveness of Artificial Intelligence as a Decision-Support System Applied to the Detection and Grading of Melanoma, Dental Caries, and Diabetic Retinopathy.
Gomez Rossi J; Rojas-Perilla N; Krois J; Schwendicke F
JAMA Netw Open; 2022 Mar; 5(3):e220269. PubMed ID: 35289862
[TBL] [Abstract] [Full Text] [Related]
14. The relative contribution of the decreasing trend in tumour thickness to the 2010s increase in net survival from cutaneous malignant melanoma in Italy: a population-based investigation.
Zamagni F; Bucchi L; Mancini S; Crocetti E; Dal Maso L; Ferretti S; Biggeri A; Villani S; Baldacchini F; Giuliani O; Ravaioli A; Vattiato R; Brustolin A; Candela G; Carone S; Carrozzi G; Cavallo R; Dinaro YM; Ferrante M; Iacovacci S; Mazzoleni G; Musolino A; Rizzello RV; Serraino D; Stracci F; Tumino R; Masini C; Ridolfi L; Palmieri G; Stanganelli I; Falcini F;
Br J Dermatol; 2022 Jul; 187(1):52-63. PubMed ID: 35253204
[TBL] [Abstract] [Full Text] [Related]
15. Survival with Cemiplimab in Recurrent Cervical cancer.
Tewari KS; Monk BJ; Vergote I; Miller A; de Melo AC; Kim HS; Kim YM; Lisyanskaya A; Samouëlian V; Lorusso D; Damian F; Chang CL; Gotovkin EA; Takahashi S; Ramone D; Pikiel J; Maćkowiak-Matejczyk B; Guerra Alía EM; Colombo N; Makarova Y; Rischin D; Lheureux S; Hasegawa K; Fujiwara K; Li J; Jamil S; Jankovic V; Chen CI; Seebach F; Weinreich DM; Yancopoulos GD; Lowy I; Mathias M; Fury MG; Oaknin A;
N Engl J Med; 2022 Feb; 386(6):544-555. PubMed ID: 35139273
[TBL] [Abstract] [Full Text] [Related]
16. HRMS Characterization, Antioxidant and Cytotoxic Activities of Polyphenols in
Navarro-Hoyos M; Arnáez-Serrano E; Quesada-Mora S; Azofeifa-Cordero G; Wilhelm-Romero K; Quirós-Fallas MI; Alvarado-Corella D; Vargas-Huertas F; Sánchez-Kopper A
Molecules; 2021 Dec; 26(23):. PubMed ID: 34885949
[TBL] [Abstract] [Full Text] [Related]
17. Expression and significance of mammalian target of rapamycin in cutaneous squamous cell carcinoma and precancerous lesions.
Xu G; Fang J; Xu J; Shen Z; Huang C; Jiang Y
Bioengineered; 2021 Dec; 12(2):9930-9938. PubMed ID: 34874800
[TBL] [Abstract] [Full Text] [Related]
18. Inpatient care for skin diseases in Germany: multi-source analysis on the current and future health care needs.
Augustin M; Girbig G; Kis A; Bechara FG; Hertl M; Hischke S; Kaufmann R; Löffler H; Müller CSL; Simon JC; Strömer K; Welzel J; Wetzig T; Elsner P; Augustin J; Löser C; Biedermann T
J Dtsch Dermatol Ges; 2021 Oct; 19 Suppl 5():25-53. PubMed ID: 34662491
[TBL] [Abstract] [Full Text] [Related]
19. OTUB1 knockdown promotes apoptosis in melanoma cells by upregulating TRAIL expression.
Lee BS; Kang SU; Huang M; Kim YS; Lee YS; Park JY; Kim CH
BMB Rep; 2021 Dec; 54(12):608-613. PubMed ID: 34488924
[TBL] [Abstract] [Full Text] [Related]
20. Development and Validation of a Modified Pathologic Nodal Classification System for Cutaneous Melanoma.
Nguyen AT; Luu M; Nguyen VP; Hamid O; Faries MB; Gharavi NM; Lu DJ; Mallen-St Clair J; Ho AS; Zumsteg ZS
JAMA Surg; 2021 Nov; 156(11):e214298. PubMed ID: 34468697
[TBL] [Abstract] [Full Text] [Related]
[Next]
